BioNTech modified RNA vaccine candidate (combined COVID-19/Influenza)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BioNTech modified RNA vaccine candidate (combined COVID-19/Influenza), covering 2025-07-23 to 2025-07-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza [Phase 2]